Financials

  • Market Capitalization 315.88 M
  • Employee 106
  • Founded 2015
  • CEO N/A
  • Website www.foghorntx.com
  • Headquarter Delaware, United States
  • FIGI BBG00HFZPB88
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.09
Rapporto prezzo/fatturato
10.79

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3230
CTNM
Contineum Therapeutics, Inc. - Common stock
14.57 USD-0.34%-0.27%+15.00%-4.58%336.55 M USD
3232
PALI
Palisade Bio, Inc. - Common Stock
1.93 USD+2.12%-5.85%+14.88%+13.53%335.01 M USD
3307
LYEL
Lyell Immunopharma, Inc. - Common Stock
13.40 USD-6.49%-14.43%+0.30%-44.61%312.68 M USD
3308
ELDN
Eledon Pharmaceuticals, Inc. - Common Stock
4.05 USD+4.92%+2.53%+17.05%+4.92%312.61 M USD

Notizie